Study of QLS5308 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an investigational drug called QLS5308 for people with advanced solid tumors that have not responded to standard treatments. The study's goal is to find a safe dose and see how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are able to do your daily activities with little or no help (ECOG 0 or 1).
- Your kidneys, liver, and bone marrow are working well enough.
- You have advanced or metastatic solid tumors (cancer that has spread) that has been confirmed by a biopsy and cannot be cured by surgery or radiation.
- You have at least one tumor that can be seen on a scan (per RECIST v1.1).
- You have not had any treatment with a LIV1-targeting drug or a topoisomerase 1 inhibitor before.
- You do not have active brain metastasis or uncontrolled fluid buildup in your chest, belly, or around your heart.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of drugs (QLC5513 and QL1706) for people with advanced or metastatic solid tumors that cannot be removed by surgery or radiation. The goal is to see if this combination is safe and effective.
This study is testing a new two-in-one immunotherapy drug (QL1706) for people with advanced cancers like lung, breast, colon, or liver cancer that have gotten worse after at least one prior treatment. It aims to see how well the drug works in real-world settings.
This trial tests a new drug, QLS5132, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug is safe and effective.
This study tests a new experimental drug called QLS5316 for people with advanced solid tumors that have not responded to standard treatments. The drug works like a 'smart bomb'—it seeks out and delivers medicine directly to cancer cells.
This trial tests a new drug called QLS5212 in people with solid tumors that have spread or cannot be removed by surgery. The goal is to see if the drug is safe and effective.
This trial tests a new drug called QLS5133 for people with advanced solid tumors that have not responded to other treatments. The drug is given alone, and the study aims to see if it is safe and effective.
Hear when a new Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.